HomeCompareNTST vs HRC

NTST vs HRC: Dividend Comparison 2026

NTST yields 4.52% · HRC yields 11.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NTST wins by $5.22M in total portfolio value· pulled ahead in Year 8
10 years
NTST
NTST
● Live price
4.52%
Share price
$19.04
Annual div
$0.86
5Y div CAGR
67.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.48M
Annual income
$5,955,978.20
Full NTST calculator →
HRC
HRC
● Live price
11.38%
Share price
$155.96
Annual div
$17.74
5Y div CAGR
40.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.26M
Annual income
$1,423,429.65
Full HRC calculator →

Portfolio growth — NTST vs HRC

📍 NTST pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNTSTHRC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NTST + HRC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NTST pays
HRC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NTST
Annual income on $10K today (after 15% tax)
$383.93/yr
After 10yr DRIP, annual income (after tax)
$5,062,581.47/yr
HRC
Annual income on $10K today (after 15% tax)
$966.88/yr
After 10yr DRIP, annual income (after tax)
$1,209,915.20/yr
At 15% tax rate, NTST beats the other by $3,852,666.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NTST + HRC for your $10,000?

NTST: 50%HRC: 50%
100% HRC50/50100% NTST
Portfolio after 10yr
$4.87M
Annual income
$3,689,703.92/yr
Blended yield
75.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NTST right now

NTST
Analyst Ratings
14
Buy
4
Hold
Consensus: Buy
Price Target
$21.17
+11.2% upside vs current
Range: $19.00 — $22.00
Altman Z
0.9
Piotroski
7/9
HRC
Analyst Ratings
7
Buy
12
Hold
1
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NTST buys
0
HRC buys
0
No recent congressional trades found for NTST or HRC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNTSTHRC
Forward yield4.52%11.38%
Annual dividend / share$0.86$17.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR67.2%40.3%
Portfolio after 10y$7.48M$2.26M
Annual income after 10y$5,955,978.20$1,423,429.65
Total dividends collected$7.32M$2.14M
Payment frequencyquarterlyquarterly
SectorREITStock
Analyst consensusBuyHold

Year-by-year: NTST vs HRC ($10,000, DRIP)

YearNTST PortfolioNTST Income/yrHRC PortfolioHRC Income/yrGap
1$11,455$755.21$12,296$1,595.93$841.00HRC
2$13,609$1,351.83$15,730$2,573.05$2.1KHRC
3$17,071$2,509.55$21,147$4,316.00$4.1KHRC
4$23,185$4,919.11$30,235$7,608.15$7.0KHRC
5$35,248$10,439.70$46,615$14,263.36$11.4KHRC
6$62,516$24,800.62$78,712$28,834.27$16.2KHRC
7$135,626$68,734.15$148,063$63,841.01$12.4KHRC
8← crossover$378,132$233,012.05$315,890$157,462.80+$62.2KNTST
9$1,419,753$1,015,152.05$778,498$440,495.17+$641.3KNTST
10$7,475,114$5,955,978.20$2,256,422$1,423,429.65+$5.22MNTST

NTST vs HRC: Complete Analysis 2026

NTSTREIT

NETSTREIT is an internally managed Real Estate Investment Trust (REIT) based in Dallas, Texas that specializes in acquiring single-tenant net lease retail properties nationwide. The growing portfolio consists of high-quality properties leased to e-commerce resistant tenants with healthy balance sheets. Led by a management team of seasoned commercial real estate executives, NETSTREIT's strategy is to create the highest quality net lease retail portfolio in the country with the goal of generating consistent cash flows and dividends for its investors.

Full NTST Calculator →

HRCStock

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Full HRC Calculator →
📬

Get this NTST vs HRC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NTST vs SCHDNTST vs JEPINTST vs ONTST vs KONTST vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.